GT199900083A - THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY. - Google Patents
THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY.Info
- Publication number
- GT199900083A GT199900083A GT199900083A GT199900083A GT199900083A GT 199900083 A GT199900083 A GT 199900083A GT 199900083 A GT199900083 A GT 199900083A GT 199900083 A GT199900083 A GT 199900083A GT 199900083 A GT199900083 A GT 199900083A
- Authority
- GT
- Guatemala
- Prior art keywords
- fragility
- therapeutic combinations
- reduction
- procedures
- musculoskeletal
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
ESTA INVENCIÒN SE REFIERE A COMPOSICIONES DE COMBINACIÒN FARMACÈUTICA Y PROCEDIMIENTOS, QUE COMPRENDEN A DOS COMPUESTOS INDICADOS COMO FÒRMULA I & II O ALGUNA DE SUS SALES FARMACÈUTICAMENTE ACEPTABLES, SE REFIERE TAMBIEN A PROCEDIMIENTOS DEL USO DE TALES COMBINACIONES Y A ESTUCHES QUE CONTIENEN TALES COMBINACIONES. LAS COMPOSICIONES SON ÙTILES PARA EL TRATAMIENTO DE LA FRAGILIDAD MUSCOLOESQUELÈTICA, INCLUYENDO LA OSTEPOROSIS, FRACTURA OSTEOPORÒTICA , REDUCCIÒN DE MASA ÒSEA, FRAGILIDAD Y REDUCCIÒN DE MASA MUSCULAR.THIS INVENTION REFERS TO PHARMACEUTICAL COMBINATION COMPOSITIONS AND PROCEDURES, WHICH INCLUDE TWO COMPOUNDS INDICATED AS FÒRMULA I & II OR SOME OF ITS PHARMACUTICALLY ACCEPTABLE SALTS, WHICH ARE ALSO USED BY THESE COMMON PROCEDURES AND THE COMPOSITIONS ARE USEFUL FOR THE TREATMENT OF MUSCOLOSKELETAL FRAGILITY, INCLUDING OSTEPOROSIS, OSTEOPORTICAL FRACTURE, REDUCTION OF MASSEA MASS, FRAGILITY AND REDUCTION OF MUSCLE MASS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8942498P | 1998-06-16 | 1998-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT199900083A true GT199900083A (en) | 2000-12-05 |
Family
ID=22217565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199900083A GT199900083A (en) | 1998-06-16 | 1999-06-14 | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY. |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1085867A1 (en) |
| JP (1) | JP2002518328A (en) |
| KR (1) | KR20010052817A (en) |
| CN (1) | CN1305378A (en) |
| AP (1) | AP9901581A0 (en) |
| AR (1) | AR018868A1 (en) |
| AU (1) | AU3342099A (en) |
| BG (1) | BG105128A (en) |
| BR (1) | BR9911357A (en) |
| CA (1) | CA2335112A1 (en) |
| CO (1) | CO5070586A1 (en) |
| EA (1) | EA200001189A1 (en) |
| GT (1) | GT199900083A (en) |
| HR (1) | HRP20000857A2 (en) |
| HU (1) | HUP0102395A2 (en) |
| ID (1) | ID26726A (en) |
| IL (1) | IL139587A0 (en) |
| IS (1) | IS5727A (en) |
| MA (1) | MA26648A1 (en) |
| NO (1) | NO20006381L (en) |
| OA (1) | OA11569A (en) |
| PA (1) | PA8472101A1 (en) |
| PE (1) | PE20000633A1 (en) |
| PL (1) | PL345064A1 (en) |
| SK (1) | SK18902000A3 (en) |
| TN (1) | TNSN99118A1 (en) |
| UY (1) | UY25557A1 (en) |
| WO (1) | WO1999065488A1 (en) |
| ZA (1) | ZA993973B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1004306A3 (en) * | 1998-08-06 | 2000-06-07 | Pfizer Products Inc. | Estrogen agonists/antagonists |
| MXPA03001771A (en) | 2000-08-30 | 2003-06-04 | Pfizer Prod Inc | SUSTAINED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGS. |
| IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| US7524866B2 (en) | 2001-11-29 | 2009-04-28 | Gtx, Inc. | Prevention and treatment of androgen—deprivation induced osteoporosis |
| DE60226494D1 (en) * | 2001-11-29 | 2008-06-19 | Gtx Inc | PREVENTIVE AND TREATMENT OF ANDROGENMANGEL INDUCED OSTEOPOROSIS |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
| CN101657436A (en) | 2007-02-09 | 2010-02-24 | 特兰齐姆制药公司 | macrocyclic ghrelin receptor modulators and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (en) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition |
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| HN1996000101A (en) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | COMBINED THERAPY FOR OSTEOPOROSIS |
-
1999
- 1999-05-03 ID IDW20002604A patent/ID26726A/en unknown
- 1999-05-03 CN CN99807381A patent/CN1305378A/en active Pending
- 1999-05-03 EA EA200001189A patent/EA200001189A1/en unknown
- 1999-05-03 CA CA002335112A patent/CA2335112A1/en not_active Abandoned
- 1999-05-03 SK SK1890-2000A patent/SK18902000A3/en unknown
- 1999-05-03 PL PL99345064A patent/PL345064A1/en unknown
- 1999-05-03 WO PCT/IB1999/000796 patent/WO1999065488A1/en not_active Ceased
- 1999-05-03 OA OA1200000346A patent/OA11569A/en unknown
- 1999-05-03 AU AU33420/99A patent/AU3342099A/en not_active Abandoned
- 1999-05-03 IL IL13958799A patent/IL139587A0/en unknown
- 1999-05-03 HR HR20000857A patent/HRP20000857A2/en not_active Application Discontinuation
- 1999-05-03 BR BR9911357-0A patent/BR9911357A/en not_active Application Discontinuation
- 1999-05-03 EP EP99914723A patent/EP1085867A1/en not_active Withdrawn
- 1999-05-03 JP JP2000554368A patent/JP2002518328A/en active Pending
- 1999-05-03 KR KR1020007014140A patent/KR20010052817A/en not_active Ceased
- 1999-05-03 HU HU0102395A patent/HUP0102395A2/en unknown
- 1999-05-07 PA PA19998472101A patent/PA8472101A1/en unknown
- 1999-06-10 AP APAP/P/1999/001581A patent/AP9901581A0/en unknown
- 1999-06-11 PE PE1999000522A patent/PE20000633A1/en not_active Application Discontinuation
- 1999-06-11 UY UY25557A patent/UY25557A1/en not_active Application Discontinuation
- 1999-06-14 GT GT199900083A patent/GT199900083A/en unknown
- 1999-06-15 TN TNTNSN99118A patent/TNSN99118A1/en unknown
- 1999-06-15 ZA ZA9903973A patent/ZA993973B/en unknown
- 1999-06-15 MA MA25622A patent/MA26648A1/en unknown
- 1999-06-15 AR ARP990102847A patent/AR018868A1/en not_active Application Discontinuation
- 1999-06-16 CO CO99037624A patent/CO5070586A1/en unknown
-
2000
- 2000-11-24 IS IS5727A patent/IS5727A/en unknown
- 2000-12-14 NO NO20006381A patent/NO20006381L/en not_active Application Discontinuation
-
2001
- 2001-01-08 BG BG105128A patent/BG105128A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3342099A (en) | 2000-01-05 |
| CO5070586A1 (en) | 2001-08-28 |
| ID26726A (en) | 2001-02-01 |
| SK18902000A3 (en) | 2001-12-03 |
| KR20010052817A (en) | 2001-06-25 |
| CN1305378A (en) | 2001-07-25 |
| UY25557A1 (en) | 2001-01-31 |
| AP9901581A0 (en) | 1999-06-30 |
| BG105128A (en) | 2001-11-30 |
| PE20000633A1 (en) | 2000-07-26 |
| BR9911357A (en) | 2001-03-13 |
| AR018868A1 (en) | 2001-12-12 |
| PL345064A1 (en) | 2001-11-19 |
| ZA993973B (en) | 2000-12-15 |
| EP1085867A1 (en) | 2001-03-28 |
| JP2002518328A (en) | 2002-06-25 |
| MA26648A1 (en) | 2004-12-20 |
| IL139587A0 (en) | 2002-02-10 |
| CA2335112A1 (en) | 1999-12-23 |
| HRP20000857A2 (en) | 2001-10-31 |
| OA11569A (en) | 2004-07-01 |
| TNSN99118A1 (en) | 2005-11-10 |
| WO1999065488A1 (en) | 1999-12-23 |
| NO20006381D0 (en) | 2000-12-14 |
| EA200001189A1 (en) | 2001-06-25 |
| PA8472101A1 (en) | 2000-09-29 |
| IS5727A (en) | 2000-11-24 |
| NO20006381L (en) | 2000-12-14 |
| HUP0102395A2 (en) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2025000288A (en) | SUBSTITUTED TETRAHYDROFURANS AS SODIUM CHANNEL MODULATORS | |
| PA8493701A1 (en) | COMPOUNDS TO TREAT OBESITY | |
| CR7716A (en) | USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT | |
| UY29265A1 (en) | COMPOUNDS OF 3H-OXAZOLO AND 3H-TIAZOLO (4,5, -D) PIRIMIDIN-2-ONA 3,5- DISUSTITUTED AND 3,5,7-TRISUSTITUIDOS AND ITS PROFESSIONALS | |
| UY27350A1 (en) | AZAINDOLS | |
| BRPI0414867A (en) | pyrazolopyridines and their analogues | |
| CO5611124A2 (en) | BENZOFURAN DERIVATIVES SUBSTITUTED USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS | |
| ECSP045069A (en) | USE OF FLIBANSERINE IN THE TREATMENT OF SEXUAL DISORDERS | |
| MXPA05011208A (en) | USE OF IVERMECTINE FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS. | |
| DK1309589T3 (en) | Urea Compounds and Methods of Use | |
| ES2064130T3 (en) | USE OF DROLOXIFENO FOR THE TREATMENT OF DISEASES OF THE BONES. | |
| ECSP034810A (en) | DERETADOS HETEROCICLILALCOXI-, -ALQUILTIO- Y - ALQUILAMINOBENZAZOL SUCH AS LIGANDOS 5-HIDROXITRIPTAMINA-6 | |
| UY29796A1 (en) | NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS | |
| BRPI0418099A (en) | compounds, pharmaceutical composition, and use of a compound | |
| ECSP055701A (en) | NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME | |
| MX2020005518A (en) | NON-RACEMIC MIXTURES AND USES THEREOF. | |
| UY28945A1 (en) | PIRROLOPIRIDINE DERIVATIVES | |
| BRPI0411673A (en) | compound, pharmaceutically acceptable salt, pharmaceutical composition, and use of a compound | |
| PA8568101A1 (en) | INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE | |
| ES2167853T3 (en) | N-ARIL 2-HYDROXY RENTED. | |
| PA8635901A1 (en) | NUCLEOSIDS OF 3-BETA-D-RIBOFURANOSILTIAZOLO [4,5-D] PYRIMIDINE AND USES OF THE SAME | |
| GT199900083A (en) | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY. | |
| UY28535A1 (en) | DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME. | |
| UY27324A1 (en) | NEW NAPSILATE SALTS I | |
| UY27132A1 (en) | NAFTOSTIRILS |